Status:
ACTIVE_NOT_RECRUITING
Genentech Validation Tool for Pulmonary Fibrosis
Lead Sponsor:
Columbia University
Collaborating Sponsors:
Genentech, Inc.
Conditions:
Interstitial Lung Disease
Eligibility:
All Genders
21+ years
Brief Summary
Radiology is an important component of the multidisciplinary team. The primary goal of this project will be to create a tool using findings on chest computed tomography (CT) for nearly 300 patients wi...
Eligibility Criteria
Inclusion
- Retrospective review of adults (age \> 21) with diagnosis of pulmonary fibrosis on chest CT and a pulmonologist report in electronic medical record confirming the working diagnosis from 1/1/2010 through 7/1/2019.
Exclusion
- Failure to meet inclusion criteria including age \< 21 and lack of a pulmonologists report in the medical record with a working diagnosis of patient's type of pulmonary fibrosis.
Key Trial Info
Start Date :
October 4 2020
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
August 1 2026
Estimated Enrollment :
400 Patients enrolled
Trial Details
Trial ID
NCT04676594
Start Date
October 4 2020
End Date
August 1 2026
Last Update
November 7 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Columbia University Irving Medical Center
New York, New York, United States, 10032